Bacteria like cholera may be crucial in the development of new antibiotics Bacteria like the cholera bacteria move around in the body through rotations from a hairy appendage on the bacteria.
Bacteria like cholera may be crucial in the development of new antibiotics Bacteria like the cholera bacteria move around in the body through rotations from a hairy appendage on the bacteria.
Giant study finds 694 new potentially harmful drug interactions Data analysis of more than one million Danish inpatients identifies new drug interactions that are associated with mortality, hospital readmission or longer hospital stays.
Giant study finds 694 new potentially harmful drug interactions Data analysis of more than one million Danish inpatients identifies new drug interactions that are associated with mortality, hospital readmission or longer hospital stays.
Oldest known molecule surprises researchers. It could lead to new important treatments Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…
Oldest known molecule surprises researchers. It could lead to new important treatments Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…
Quarantine system update The quarantine from unit 16.4 to the Biocenter has been repealed, which means that animals and personnel can now move freely between these two units without quarantine restrictions. The quarantine restriction between…
Maintenance work at Panum The service water will be closed on Thursday, August 17th in building 10 at Panum between 11:30 and 15:00. Sorry for any inconveniences.
NNF Challenge Programme grant of DKK 60 awarded to Professor Nikos Hatzakis The Novo Nordisk Foundation has awarded a Challenge Programme grant of DKK 60 million to Professor Nikos Hatzakis for realising the drugs of the future.
Refurbishment of breeding unit 10-4 in the Panum Building AEM is in collaboration with Campus Service (CAS) planning a much needed renovation of the breeding unit at 10-4 in the Panum Building which will commence April 2024. Prior to that the unit needs to be vacated. AEM will…
Thousands suffer from tabooed disease. New method makes it easier to identify the right treatment More than 10 urgent visits to the bathroom a day due to diarrhoea can make it virtually impossible to lead a normal life. But new research can help doctors diagnose bile acid diarrhoea and find the right treatment.
Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels BRIC/Finsen Group Leader, Michael Ploug, and his Network Receives a Research Grant to Study the breakdown of fat in the smallest blood vessels.
Need help to quit smoking? Known drug might help reduce nicotine cravings A drug that was originally developed to treat diabetes and severe overweight might also help people with nicotine dependence, concludes new research from the University of Copenhagen.
PartoMa at IMNHC: The injustice of unfit clinical guidelines in women’s and children’s health On Wednesday, May 10th, the PartoMa team will host a thematic session at IMNHC titled "The Missing Link between Clinical Guidelines and Clinical Realities: Aligning Together." The session will be moderated by Thomas van…
CBMR secures five-year funding extension from Novo Nordisk Foundation Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation.
The University of Copenhagen invests in the development of medicines from health-promoting gut bacteria The University of Copenhagen is the first Danish university to invest in a company based on its own research in a unique collaboration with a venture fund. In April 2023, the spinout GutCRINE ApS received initial fundin…
BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.
Hormone predicts ability to maintain weight loss The appetite hormone neurotensin released by the intestine upon eating may predict our ability to maintain weight loss, new study from the University of Copenhagen concludes.
New malaria study is good news for pregnant women Each year, 13 million pregnant women get malaria, and as drug resistance increases, the disease is hard to control. A new study provides the WHO with new knowledge on prevention and treatment.
Risk of heart problems makes Danes get flu vaccination More Danes got vaccinated for the seasonal flu if they received a nudging letter from the health authorities, which linked the flu and the risk of subsequent heart problems, study concludes.
Bartender model predicts how drugs affect each person A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.
Bartender model predicts how drugs affect each person A model based on numerous studies of people with type 2 diabetes can make a new type of prediction: how a certain drug would affect each person at the molecular biological level.
Resistant bacteria are a global problem. Now researchers may have found the solution A new substance has proven useful for treating staphylococcus infections in people with skin lymphoma. This is good news for the patients, but also for the global threat of antibiotics resistance.
The deadline for the submission to European Journal of Pharmaceutical Sciences VSI: Nordic POP has been extended until May 31 Good news for those that are planning to submit to European Journal of Pharmaceutical Sciences VSI: Nordic POP and are running a bit late!. The submission deadline has been moved to May 31, 2023. Hope for a rush of…